Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

This study is currently recruiting participants.
Verified October 2013 by Northwestern University
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Lorenzo Gallon, Northwestern University
ClinicalTrials.gov Identifier:
First received: March 19, 2009
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)